Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 57,700 | 54,040 | 70,936 | 62,922 | 76,646 |
| Operating Income | -57,700 | -54,040 | -70,936 | -62,922 | -76,646 |
| Interest Expense | 747 | 0 | 0 | 0 | 0 |
| Other Income | 1,692 | 1,334 | 3,049 | 4,103 | 4,152 |
| Pre-tax Income | -56,755 | -52,706 | -67,887 | -58,819 | -72,494 |
| Income Tax | N/A | 25 | 105 | N/A | 53 |
| Net Income Continuous | -56,755 | -52,731 | -67,992 | -58,819 | -72,547 |
| Net Income | $-56,755 | $-52,731 | $-67,992 | $-58,819 | $-72,547 |
| EPS Basic Total Ops | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 |
| EPS Basic Continuous Ops | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 |
| EPS Diluted Total Ops | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 |
| EPS Diluted Continuous Ops | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 |
| EPS Diluted Before Non-Recurring Items | -0.35 | -0.33 | -0.42 | -0.37 | -0.45 |
| EBITDA(a) | $-58,289 | $-54,917 | $-72,068 | $-63,846 | $-77,816 |